NEW YORK STATE COMMON RETIREMENT FUND has added 292,451 shares of $WLK to their portfolio, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 06-30-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $WLK.
WESTLAKE CHEMICAL Hedge Fund Activity
We have seen 185 institutional investors add shares of WESTLAKE CHEMICAL stock to their portfolio, and 220 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NORGES BANK added 967,104 shares (+237.8%) to their portfolio in Q2 2025, for an estimated $73,432,206
- ANTIPODES PARTNERS LTD added 823,169 shares (+inf%) to their portfolio in Q2 2025, for an estimated $62,503,222
- MILLENNIUM MANAGEMENT LLC added 708,142 shares (+366.7%) to their portfolio in Q1 2025, for an estimated $70,835,444
- FIRST TRUST ADVISORS LP removed 660,957 shares (-79.9%) from their portfolio in Q1 2025, for an estimated $66,115,528
- VICTORY CAPITAL MANAGEMENT INC added 586,178 shares (+17.7%) to their portfolio in Q1 2025, for an estimated $58,635,385
- ILEX CAPITAL PARTNERS (UK) LLP added 546,991 shares (+359.8%) to their portfolio in Q1 2025, for an estimated $54,715,509
- BALYASNY ASSET MANAGEMENT L.P. removed 471,274 shares (-47.5%) from their portfolio in Q1 2025, for an estimated $47,141,538
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
WESTLAKE CHEMICAL Insider Trading Activity
WESTLAKE CHEMICAL insiders have traded $WLK stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $WLK stock by insiders over the last 6 months:
- ROBERT F. BUESINGER (EVP, PEM Segment Head) has made 1 purchase buying 83 shares for an estimated $7,751 and 1 sale selling 83 shares for an estimated $6,034.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
WESTLAKE CHEMICAL Analyst Ratings
Wall Street analysts have issued reports on $WLK in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 07/15/2025
- UBS issued a "Buy" rating on 07/09/2025
- Citigroup issued a "Buy" rating on 07/08/2025
- RBC Capital issued a "Outperform" rating on 07/03/2025
- B of A Securities issued a "Buy" rating on 06/18/2025
- Truist Securities issued a "Buy" rating on 05/30/2025
- Barclays issued a "Overweight" rating on 05/05/2025
To track analyst ratings and price targets for WESTLAKE CHEMICAL, check out Quiver Quantitative's $WLK forecast page.
WESTLAKE CHEMICAL Price Targets
Multiple analysts have issued price targets for $WLK recently. We have seen 14 analysts offer price targets for $WLK in the last 6 months, with a median target of $94.5.
Here are some recent targets:
- Jeffrey Zekauskas from JP Morgan set a target price of $73.0 on 08/12/2025
- Bhavesh Lodaya from BMO Capital set a target price of $94.0 on 08/06/2025
- Neel Kumar from Morgan Stanley set a target price of $90.0 on 08/06/2025
- John Roberts from Mizuho set a target price of $98.0 on 07/15/2025
- Michael Sison from Wells Fargo set a target price of $90.0 on 07/14/2025
- Joshua Spector from UBS set a target price of $99.0 on 07/09/2025
- Patrick Cunningham from Citigroup set a target price of $95.0 on 07/08/2025
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $WLK ticker page for more data.
